Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/12/2025

Initial Management of Sepsis

Antimicrobial Therapy

  • Administer intravenous broad-spectrum antibiotics within the first hour of sepsis recognition, as each hour of delay increases mortality by 7.6% 1, 2
  • The Surviving Sepsis Campaign recommends starting antimicrobial therapy immediately, with the goal of administering the first dose within one hour of sepsis recognition 1, 2
  • Obtain at least two sets of blood cultures (aerobic and anaerobic) before starting antibiotics, but do not delay antibiotic administration to obtain cultures 1, 2
  • Perform appropriate cultures according to local protocol (urine, wounds, etc.) 1, 3

Selection of Empiric Antibiotics

  • Use empiric broad-spectrum antibiotic therapy covering all likely pathogens (bacterial, fungal, viral) 1, 2, 4
  • For septic shock, consider using a combination of antibiotics, including a beta-lactam and an aminoglycoside or a fluoroquinolone, but do not use combination therapy routinely for other severe infections 1, 2
  • The American College of Critical Care Medicine recommends using a beta-lactam antibiotic, such as piperacillin-tazobactam, meropenem, or imipenem-cilastatin, as the initial empiric therapy for septic shock 5, 2

Hemodynamic Resuscitation

  • Restore cardiovascular function aggressively within the first 6 hours with goal-directed fluid resuscitation 3, 2
  • Target a mean arterial pressure of ≥ 65 mmHg, central venous pressure of 8-12 mmHg, and urine output of ≥ 0.5 ml/kg/h 3, 2
  • Administer ≥ 30 ml/kg of crystalloids immediately to adults in septic shock 2

Optimization of Antimicrobial Therapy

  • Optimize dosing strategies according to accepted pharmacokinetic/pharmacodynamic principles and specific drug properties 1, 5
  • Consider prolonged or continuous infusion of beta-lactam antibiotics to maximize time above the minimum inhibitory concentration 5

De-escalation and Duration of Therapy

  • De-escalate antimicrobial therapy once the pathogen is identified and sensitivities are established, and/or adequate clinical improvement is noted 1, 4
  • Discontinue combination therapy within the first few days in response to clinical improvement 1
  • A duration of 7-10 days is adequate for most severe infections associated with sepsis and septic shock, but longer durations may be necessary in certain cases 1, 2

Source Control

  • Perform urgent surgical debridement of necrotic tissue as soon as medically possible, ideally within 12 hours 5
  • Inadequate source control requires longer antibiotic courses 5

Common Pitfalls to Avoid

  • Do not delay antibiotics to obtain cultures or establish vascular access 1, 2
  • Do not use prolonged systemic antimicrobial prophylaxis in patients with severe inflammatory conditions of non-infectious origin 1
  • Do not continue combination therapy beyond 3-5 days without clear justification 1, 5